+499.5%
MRNA vs NVD
-61.9%
+561.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.4% | -0.9% | -2.2% |
| 7D | +5.5% | -11.1% | +16.6% | +5.5% |
| 30D | +158.7% | -13.3% | +172.0% | +159.0% |
| 3M | +182.1% | -19.8% | +202.0% | +184.3% |
| 6M | +151.8% | -48.8% | +200.6% | +143.8% |
| YTD | +393.6% | -49.7% | +443.2% | +376.5% |
| 1Y | +499.5% | -61.4% | +560.8% | +460.0% |
| All | +499.5% | -61.9% | +561.3% | +460.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NVD.
Daily Out/Under-Performance
Portfolio return minus NVD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling